StoneX Group Inc.

Position in PFE — Pfizer Inc

CIK 913760 New York, NY

Position in PFE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$805,957

+$8,317 QoQ

Shares Held

33,470

+17.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#1,451

of 2,821 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

StoneX Group Inc. holds $35,939,835 across 13 Drug Manufacturers - General names. PFE ranks #6 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	32,707	$8,230,389
2	LLY	ELI LILLY & Co	6,635	$7,958,218
3	JNJ	Johnson & Johnson	27,201	$6,908,237
4	MRK	Merck & Co., Inc.	42,565	$5,469,602
5	AMGN	Amgen Inc	12,416	$4,496,081
6	PFE	Pfizer Inc This page	33,470	$805,957
7	BMY	Bristol Myers Squibb Co	9,503	$547,562
8	NVS	Novartis AG	2,818	$441,636

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$805,957	33,470	+17.8%	Shares	Defined	2026-08-12
2026-03-31	$797,640	28,406	-23.6%	Shares	Defined	2026-05-14
2025-12-31	$925,881	37,184	-6.9%	Shares	Defined	2026-02-12
2025-09-30	$1,018,027	39,954	-2.7%	Shares	Defined	2025-11-14
2025-06-30	$995,318	41,061	+68.8%	Shares	Defined	2025-08-13
2021-09-30	$1,046,046	24,321	-11.8%	Shares	Defined	2021-10-20
2021-06-30	$1,080,071	27,581	+12.4%	Shares	Defined	2021-08-06
2021-03-31	$888,721	24,530	+14.0%	Shares	Defined	2021-06-30
2020-12-31	$792,298	21,524	+32.3%	Shares	Defined	2021-02-03
2020-09-30	$597,218	16,273	+26.0%	Shares	Defined	2020-11-12
2020-06-30	$422,190	12,911	-6.8%	Shares	Defined	2020-08-12
2020-03-31	$452,193	13,854	—	Shares	Defined	2020-04-30
No filing history on record for this holder in this stock.